Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Opinion
August 19, 2019 02:02 PM

Commentary: Behind-the-scenes decisionmaking limits doctor-recommended treatments for sickest Americans

Kenneth Thorpe
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Kenneth Thorpe, Ph.D., is the Robert W. Woodruff Professor and chair of the Department of Health Policy and Management in the Rollins School of Public Health at Emory University.

    As many as 50 million Americans are living with some kind of autoimmune disease illnesses in which dysfunctional immune systems attacks healthy tissues and organs, leading to painful, life-affecting conditions like psoriatic or rheumatoid arthritis, multiple sclerosis and Crohn's disease. These diseases are difficult to diagnose, complicated to treat and usually involve painstaking work by physicians to determine just the right medication, or combination of medications, that will bring the autoimmune sufferer some level of relief and the ability to live as close to a normal life as the illness will allow.

    Many of these patients are unaware that their health insurance companies are restricting access to the treatments their doctors have deemed most effective. A disturbingly high number of health plans are geared to override the judgment of physicians and give patients the medicines that they—the insurers—want them to take. For those with complex autoimmune challenges, the ramifications of taking the wrong medicine can be severe.

    A research team from Emory University evaluated the formularies of thousands of private health plans and Medicare coverage plans, specifically looking at the access they provide to medicines for five serious autoimmune conditions. The results are both startling and distressing.

    The vast majority of private health plans and insurance options in the Medicare Part D prescription drug program impose significant to austere restrictions on access to treatments for these autoimmune conditions. In fact, fewer than 3% of plans nationwide offered what we would define as meaningful access to medicines at the pharmacy. Interestingly, these plans offer much broader access to medicines administered in a hospital or physician's office.

    It's at the pharmacy counter where these access restrictions have the greatest detrimental effect on patients.

    Some plans require the cumbersome, time-consuming process of prior authorization before patients can begin taking the medicines their physicians deem essential. Some require higher out-of-pocket spending for certain drugs in an effort to drive patients toward therapies that are better for the insurer's bottom line. And then there is the particularly insidious policy known as step therapy, "or fail first," in which patients are forced to try insurer-preferred medication options first until they have proven to be harmful or ineffective, at which point, they can finally transition to the medications their doctors initially ordered. Needless to say, these delays are significantly more harmful for individuals already suffering from a serious illness.

    Patients also run into what is known as the "rebate wall." Health insurers and pharmacy benefit managers negotiate sizable rebates on particular drugs and then direct their patient-customers to use those drugs because greater utilization means more rebate dollars going into their bank accounts.

    Just because certain treatments haven't achieved volume in the marketplace doesn't mean that patients shouldn't have access to them. Oftentimes, these medications—which can include less costly generics and complex biosimilars for autoimmune diseases—are the catalysts for future innovation. Restricting access can equate to less R&D investment over time, which slows the pace of innovation.

    We initiated and are sharing this research because this trend warrants closer examination and concern. There are currently proposals being considered at the federal level that would expand coverage restrictions to more patients dealing with serious illnesses. The CMS is considering changes that would allow Medicare Part D plans to cover fewer medicines and use approaches like step therapy for more therapeutic classes of medications. These changes would apply to Medicare beneficiaries who are already stable and doing well on the medications they are currently taking, forcing changes that could disrupt their care and undermine their health.

    This research and countless patient case studies should prompt a discussion of how we define health insurance and as how we, as a nation, strive to improve population health and responsibly reduce healthcare costs. Making people sicker by manipulating the medicines they take for financial gain would seem to be a flawed strategy if our goal is indeed to have a healthier America.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    20160830_Mike_Pykosz_mm0146(1).jpg
    Q&A: Oak Street Health CEO on growth plans after CVS Health deal
    Rapid growth predicted for hospital-at-home market
    Rapid growth predicted for hospital-at-home market
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing